Clinical trial
Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in…
NCT00102752 · Threshold Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00102752 |
|---|---|
| Title | Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer |
| Official title | A Phase 1/2 Dose-Escalation Study of the Safety, Efficacy and Pharmacokinetics of Glufosfamide in Combination With Gemcitabine in Advanced Solid Tumors and Pancreatic Adenocarcinoma |
| Lead sponsor | Threshold Pharmaceuticals, Industry |
| Collaborators | PPD Development, LP Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasms, Pancreatic Neoplasms |
| Intervention type | Drug |
| Interventions | Glufosfamide, Gemcitabine |
| Enrollment | 47 |
| Start date | Dec 1, 2004 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Feb 2, 2005 |
| Last update posted | Apr 30, 2009 |
| Countries | Brazil, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: